Julian Naglik

Prof. Julian Naglik

Mucosal and Salivary Biology Division, King’s College London Dental Institute, King’s College London, London, United Kingdom
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2003 in Microbiology and Molecular Biology Reviews
Verified
Journal Article
Closed access
PDF file
JNJulian Naglik
Julian Naglik
SCStephen Challacombe
Stephen Challacombe
Bernhard HubeBernhard Hube
Bernhard Hube
SUMMARY: Candida albicans is the most common fungal pathogen of humans and has developed an extensive repertoire of putative virulence mechanisms that allows successful colonization and infection of the host under suitable predisposing conditions. Extracellular proteolytic activity plays a central role in Candida pathogenicity and is produced by a family of 10 secreted aspartyl proteinases (Sap proteins). Although the consequences of proteinase secretion during human infections is not precisely known, in vitro, animal, and human studies have implicated the proteinases in C. albicans virulence in one of the following seven ways: (i) correlation between Sap production in vitro and Candida virulence, (ii) degradation of human proteins and structural analysis in determining Sap substrate specificity, (iii) association of Sap production with other virulence processes of C. albicans, (iv) Sap protein production and Sap immune responses in animal and human infections, (v) SAP gene expression during Candida infections, (vi) modulation of C. albicans virulence by aspartyl proteinase inhibitors, and (vii) the use of SAP-disrupted mutants to analyze C. albicans virulence. Sap proteins fulfill a number of specialized functions during the infective process, which include the simple role of digesting molecules for nutrient acquisition, digesting or distorting host cell membranes to facilitate adhesion and tissue invasion, and digesting cells and molecules of the host immune system to avoid or resist antimicrobial attack by the host. We have critically discussed the data relevant to each of these seven criteria, with specific emphasis on how this proteinase family could contribute to Candida virulence and pathogenesis.

30 March 2016 in Nature
Verified
Journal Article
Open access
PDF file
DMDavid Moyes
David Moyes
DWDuncan Wilson
Duncan Wilson
JRJonathan Richardson
Jonathan Richardson
SMSelene Mogavero
Selene Mogavero
STShirley X. Tang
Shirley X. Tang
JNJulian Naglik
Julian Naglik
Cytolytic proteins and peptide toxins are classical virulence factors of several bacterial pathogens which disrupt epithelial barrier function, damage cells and activate or modulate host immune responses. Such toxins have not been identified previously in human pathogenic fungi. Here we identify the first, to our knowledge, fungal cytolytic peptide toxin in the opportunistic pathogen Candida albicans. This secreted toxin directly damages epithelial membranes, triggers a danger response signalling pathway and activates epithelial immunity. Membrane permeabilization is enhanced by a positive charge at the carboxy terminus of the peptide, which triggers an inward current concomitant with calcium influx. C. albicans strains lacking this toxin do not activate or damage epithelial cells and are avirulent in animal models of mucosal infection. We propose the name ‘Candidalysin’ for this cytolytic peptide toxin; a newly identified, critical molecular determinant of epithelial damage and host recognition of the clinically important fungus, C. albicans.

1 November 2005 in Current Biology
Verified
Journal Article
Closed access
TKTorsten Klengel
Torsten Klengel
WLWei-Jun Liang
Wei-Jun Liang
JCJames Chaloupka
James Chaloupka
CRClaudia Ruoff
Claudia Ruoff
KSKlaus Schröppel
Klaus Schröppel
FMFritz A. Mühlschlegel
Fritz A. Mühlschlegel

1 September 2010 in Cell Host & Microbe
Verified
Journal Article
Open access
DMDavid Moyes
David Moyes
MRManohursingh Runglall
Manohursingh Runglall
CMCelia Murciano
Celia Murciano
CSChengguo Shen
Chengguo Shen
DNDeepa Nayar
Deepa Nayar
JNJulian Naglik
Julian Naglik
Discriminating between commensal and pathogenic states of opportunistic pathogens is critical for host mucosal defense and homeostasis. The opportunistic human fungal pathogen Candida albicans is also a constituent of the normal oral flora and grows either as yeasts or hyphae. We demonstrate that oral epithelial cells orchestrate an innate response to C. albicans via NF-κB and a biphasic MAPK response. Activation of NF-κB and the first MAPK phase, constituting c-Jun activation, is independent of morphology and due to fungal cell wall recognition. Activation of the second MAPK phase, constituting MKP1 and c-Fos activation, is dependent upon hypha formation and fungal burdens and correlates with proinflammatory responses. Such biphasic response may allow epithelial tissues to remain quiescent under low fungal burdens while responding specifically and strongly to damage-inducing hyphae when burdens increase. MAPK/MKP1/c-Fos activation may represent a "danger response" pathway that is critical for identifying and responding to the pathogenic switch of commensal microbes.

10 January 2012 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
Ilse JacobsenIlse Jacobsen
Ilse Jacobsen
DWDuncan Wilson
Duncan Wilson
BWBetty Wächtler
Betty Wächtler
Sascha BrunkeSascha Brunke
Sascha Brunke
JNJulian Naglik
Julian Naglik
BHBernhard Hube
Bernhard Hube
The ability to switch between yeast and hyphal growth forms (dimorphism) is one of the most discussed and best investigated virulence attributes of the human pathogenic fungus Candida albicans. Both morphological forms seem to be important for virulence and have distinct functions during the different stages of disease development, including adhesion, invasion, damage, dissemination, immune evasion and host response. In this review, we will provide an overview of the known and potential roles of C. albicans dimorphism and will discuss the potential benefit of drugs that can inhibit the morphological transition.

16 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
XLXin V. Li
Xin V. Li
ILIrina Leonardi
Irina Leonardi
GPGregory G. Putzel
Gregory G. Putzel
ASAlexa Semon
Alexa Semon
WFWilliam D. Fiers
William D. Fiers
IIIliyan D. Iliev
Iliyan D. Iliev